<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: AUGUST 17, 2000
ISONICS CORPORATION
(Name of small business issuer as specified in its charter)
CALIFORNIA 001-12531 77-0338561
---------- --------- ----------
State of Commission File IRS Employer
Incorporation Number Identification No.
5906 MCINTYRE STREET, GOLDEN, COLORADO 80403
--------------------------------------------
Address of principal executive offices
303-279-7900
------------
Telephone number, including
Area code
NOT APPLICABLE
--------------
Former name or former address if changed since last report
<PAGE>
ITEM 5 - OTHER EVENTS
GENERAL. Isonics filed a registration statement on Form S-4 for an
exchange offer by which the Company will offer to exchange its outstanding
Class A Redeemable Purchase Stock Purchase Warrants (the Class A Warrants")
for newly-created Class B Common Stock Purchase Warrants (the "Class B
Warrants) which became effective on June 12, 2000. The Company has decided
that it is in its best interests to extend the expiration date of the
exchange offer and the Class B Warrants from September 30, 2000 to and
including April 30, 2001. Consequently the Company and its transfer agent
(acting as Exchange Agent) have entered into an amendment to the Class B/C
Warrant Agreement by which the expiration date of the Class B warrants and
the exchange offer itself has been extended to and including April 30, 2001.
Isonics expects to file a post-effective amendment to its Form S-4
registration statement in the near future to reflect this extension. The
extension is effective immediately, but persons will not be entitled to
exchange their Class A Warrants under the exchange offer until such
post-effective amendment has become effective.
Isonics is an advanced materials and technology company which develops and
commercializes products based on enriched stable isotopes. Enriched stable
isotopes can be thought of as ultra-ultra pure materials. This high degree of
purification provides enhanced performance properties compared to normal
materials. Stable isotopes have commercial uses in several areas, including
energy; research, medical diagnostics, and drug development; product tagging and
stewardship; semiconductors; lasers; and optical materials.
Except for historical information contained herein, this document contains
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements involve known and unknown risks
and uncertainties that may cause the Company's actual results or outcomes to be
materially different from those anticipated and discussed herein. Further, the
Company operates in industries where securities values may be volatile and may
be influenced by regulatory and other factors beyond the Company's control.
Other important factors that the Company believes might cause such differences
are discussed in the risk factors detailed in the Company's 10-KSB for the year
ended April 30, 1999 filed with the Securities and Exchange Commission, which
include the Company's cash flow difficulties, dependence on significant
customers, and rapid development of technology, among other risks. In assessing
forward-looking statements contained herein, readers are urged to carefully read
all cautionary statements contained in the Company's filings with the Securities
and Exchange Commission.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial statements of businesses acquired. NOT APPLICABLE.
(b) Pro forma financial statements. NOT APPLICABLE.
(c) Exhibits:
1. Amendment No. 1 to the Warrant Agreement dated as of June 1, 2000
between Isonics Corporation and Continental Stock Transfer & Trust
Company (included herewith)
2. Warrant Agreement dated as of June 1, 2000 between Isonics Corporation
and Continental Stock Transfer & Trust Company (incorporated by
reference from Exhibit 4.05 to the registration statement on Form S-4
filed by Isonics Corporation (commission file no. 333-37696).
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized, on the 17th day of August 2000.
ISONICS CORPORATION
By: /s/ James E. Alexander
-------------------------------------
James E. Alexander
President and Chief Executive Officer
